Home
Clinical Trials
About Us
Company Overview
Board of Directors
Senior Management
Corporate Directory
Corporate Governance
Lead Candidate
Overview
Clinical Trials
Completed Trials
Microparticle Platform
Publications
Investor Information
Welcome
Investor Fact Sheet
Top 20 Shareholders
Key Dates
Capital Structure
Shareholder Services
Investor FAQs
News & Reports
ASX Announcements
Annual Reports
Media Coverage
Presentations
Patient and Media Reports
Email Alerts
Contact Us
Contact Us
Email Alerts
Innate Immunotherapeutics Limited
Home
>
News & Reports
>
ASX Announcements
>
Print Page
ASX Announcements
Filter by Year:
2015
2014
2013
12-Dec-2014
Compassionate Use Program Update
20-Nov-2014
Half Yearly Report and Accounts
11-Nov-2014
Patient Dosing Commences and Appointment of Dr Mansell
31-Oct-2014
Appendix 4C - September 2014 Quarter
24-Oct-2014
Appendix 3B - Employee Options
7-Oct-2014
Update on Innate's Phase 2B trial and recent activities
18-Sep-2014
Change of Director's Interest Notice - S. Wilkinson
18-Sep-2014
Appendix 3B - AGM approved Options to CEO
20-Aug-2014
Results of Meeting - AGM
20-Aug-2014
CEO Address to AGM
Pages:
1
2
3
ASX Announcements
Annual Reports
Media Coverage
Presentations
Patient and Media Reports
Email Alerts